Provepharm Inc.
Provepharm Inc. appears in FDA public data with 2 recalls — including 1 Class I (most serious) —, 0 510(k) clearances, 3 FDA inspections, and 0 compliance actions on record. Its most recent recall (D-0230-2025, Class I) was initiated on January 21, 2025.
Summary
- Total Recalls
- 2 (1 Class I)
- 510(k) Clearances
- 0
- Inspections
- 3
- Compliance Actions
- 0
Recent Recalls
| Number | Class | Product | Date |
|---|---|---|---|
| D-0230-2025 | Class I | Phenylephrine HCl Injection, USP 100 mg/10 mL (10 mg/mL) vials, Rx only, Pharmacy Bulk Package (supp | January 21, 2025 |
| D-0150-2025 | Class II | Dihydroergotamine Mesylate Injection, solution for injection, USP, 1 mg/mL Ampules, Rx Only, Distrib | November 22, 2024 |